PhaseBio recently received formal written minutes from the FDA following its Pre-BLA Meeting held in early April and is expecting to submit its Biologics License Application (BLA) by early in the fourth quarter of 2022 The FDA indicated willingness to accept a BLA with data from 25-30 uncontrolled bleeding patients, in addition to surgical patients … [Read more…]
Held successful Type B pre-biologics license application (BLA) meeting with U.S. FDA for future submission of BLA for bentracimab BLA submission for bentracimab is planned for early in the fourth quarter of 2022 and PhaseBio is preparing for commercialization in U.S., if approved Presented positive results from Phase 2b trial for bentracimab at ACC.22 Completed … [Read more…]
— Under the expanded collaboration, Proteros will receive additional research funding, milestone payments plus royalties — MUNICH–(BUSINESS WIRE)–Proteros biostructures GmbH (“Proteros”), an expert in integrated structure-based drug discovery, announces today an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) focused on the discovery and development of novel epigenetic drugs. The new multi-year agreement builds on … [Read more…]
GARCHING, Germany & MUNICH–(BUSINESS WIRE)–ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will host a scientific symposium on precision oncology titled “Targeted Radionuclide Therapy – present and future prospects” held as an ancillary event in parallel to the 2022 ASCO® Annual Meeting. The symposium will feature key opinion … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028” report has been added to ResearchAndMarkets.com’s offering. During the last few decades, there has been enormous development in the field of delivery systems to provide therapeutic agents or natural based active compounds to the target location for the management of several … [Read more…]
Where the balance of mind, body, and spirit is restored through the ancient and time-tested tenets of Ayurveda KERALA, India–(BUSINESS WIRE)–The newly-launched Amal Tamara in Alleppey, Kerala, is Tamara Leisure Experiences’ first foray into luxury wellness Ayurveda experiences. This 19-key property continues to hold the company’s core values of Responsible Hospitality at the root of … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Hand Sanitizer Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029” report has been added to ResearchAndMarkets.com’s offering. Hand sanitizer which was largely used in North America that accounted for almost 45% of market revenues precovid, has become a household product in Asia … [Read more…]
— Patients enrolled in the pivotal trials increased daily ON time without dyskinesia by 2.9 hours with GOCOVRI compared to placebo, through the reduction of both OFF time and dyskinesia – — GOCOVRI is the first and only therapy for the treatment of OFF and/or dyskinesia for patients with Parkinson’s disease on levodopa-based therapy – … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Chronic Myeloid Leukemia (CML) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2019 to 2029” report has been added to ResearchAndMarkets.com’s offering. The report provides detailed intelligence about the chronic myeloid leukemia (CML) treatment market. The report includes detailed analysis on market dynamics, market … [Read more…]
Arscimed® (arsenic trioxide) reaches an impressive 75% clinical efficacy at 6 months when administered intraveinously over one month to moderate to severe cGvHD patients Primary efficacy endpoint met: complete or partial disease remission at 6 months and sustained response at 12 months Very significant reduction in corticosteroid use STRASBOURG, France–(BUSINESS WIRE)–Medsenic, a clinical stage biopharmaceutical … [Read more…]
